Inogen reported $0 in Loan Capital for its fiscal quarter ending in June of 2022.





Loan Capital Change Date
Abbott USD 29.45B 152M Sep/2026
Accuray USD 124.78M 2.54M Dec/2025
AngioDynamics USD 5.6M 100K Sep/2025
Artivion USD 363.79M 364K Sep/2026
AtriCure USD 61M 0 Sep/2026
Baxter International USD 8.62B 6M Jun/2026
Becton, Dickinson and Co. USD 13.42B 89M Sep/2026
Boston Scientific USD 10.79B 73M Jun/2026
Cooper Companies USD 1.92B 54.8M Jun/2026
Dexcom USD 1.3B 200K Jun/2026
Edwards Lifesciences USD 598.8M 100K Sep/2026
Globus Medical USD 326K 54K Sep/2026
Inogen USD 0 0 Jun/2022
Insulet USD 943M 13.5M Sep/2026
Medtronic USD 25.62B 502M Jun/2026
Orthofix International USD 221.85M 256K Sep/2026
Philips EUR 6.98B 669M Sep/2026
ResMed USD 399.42M 4.75M Jun/2026
Steris USD 1.65B 100K Sep/2026
Stryker USD 14.18B 16M Sep/2026
Tandem Diabetes Care USD 603.39M 811K Sep/2026
Teleflex USD 1.53B 1.19B Sep/2026
X T L Biopharmaceuticals USD 0 0 Dec/2024
Zimmer Biomet Holdings USD 6.22B 61M Sep/2026